Chronic inhibition of ERK1/2 signaling improves disordered bone and mineral metabolism in hypophosphatemic (Hyp) mice

Medicine and Dentistry

• N (2,3 Dihydroxypropoxy) 3,4 Difluoro 2 (2 Fluoro 4 Iodoanilino)benzamide 50%
• Serum 30%
• Bone Disease 30%
• Protein 20%
• Mineralization 20%
• Bone Mass 20%
• Metabolism 20%
• Fibroblast Growth Factor 23 20%
• Cortical Bone 20%
• Osteoid 20%
• Mineral Metabolism 20%
• Analysis 20%
• Mitogen-Activated Protein Kinase 20%
• Messenger RNA 10%
• Phosphate 10%
• Oxygenase 10%
• Mitogen Activated Protein Kinase 3 10%
• Cancellous Bone 10%
• Epiphysis 10%
• Epiphyseal Plate 10%
• X-Ray Microtomography 10%
• Loss of Function Mutation 10%
• Bone Mineralization 10%
• Hypophosphatemia 10%
• MAPK Signaling 10%
• Sodium Phosphate Cotransporter 10%
• Gene 10%
• Bone Metabolism 10%

Biochemistry, Genetics and Molecular Biology

• Mouse 100%
• Bone 50%
• Mineralization 20%
• Mitogen-Activated Protein Kinase 20%
• Metabolic Pathway 20%
• Bone Mass 20%
• Osteoid 20%
• Fibroblast Growth Factor 23 20%
• Protein 20%
• Thickness 20%
• Phosphate 20%
• Nested Gene 10%
• Cotransporter 10%
• MAPK Signaling 10%
• Loss of Function Mutation 10%
• Micro-Computed Tomography 10%
• Growth 10%
• Hypophosphatemia 10%
• Volume 10%
• Messenger RNA 10%
• Bone Mineralization 10%